Antibiotic-impregnated grafts for aortic reconstruction

Seminars in Vascular Surgery

Volumn 24, Issue 4, 2011, Pages 211-219

  Lew, Wesley ^a   Moore, Wesley ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BENZALKONIUM; CEFAZOLIN; CEFOXITIN; CEPHALOSPORIN; CHLORAMPHENICOL; CHLORTETRACYCLINE; COLLAGEN; GELATIN; GENTAMICIN; NEOMYCIN; OXACILLIN; RIFAMPICIN;

AMPUTATION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; AORTA GRAFT; AORTA RECONSTRUCTION; ARTICLE; DACRON VASCULAR PROSTHESIS; EXCISION; GRAFT INFECTION; GRAFT OCCLUSION; HUMAN; INFECTION RESISTANCE; LAVAGE; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MORTALITY; NONHUMAN; POLITEF IMPLANT; PRIORITY JOURNAL; REINFECTION; SURGICAL TECHNIQUE; SURVIVAL RATE; THORACIC AORTA; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; AORTA; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CROSS INFECTION; DEVICE REMOVAL; HUMANS; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RECURRENCE; REOPERATION; TREATMENT OUTCOME;

EID: 84855475846     PISSN: 08957967     EISSN: 15584518     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2011.10.015     Document Type: Article

References (46)

1. Quinones-Baldrich W.J., Hernandez J.J., Moore W.S. Long-term results following surgical management of aortic graft infection. Arch Surg 1991, 126:507-511.
2. Reilly L.M., Altman H., Lusby R.J., et al. Late results following surgical management of vascular graft infection. J Vasc Surg 1984, 1:36-44.
3. O'Hara P.J., Hertzer N.R., Beven E.G., et al. Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J Vasc Surg 1986, 3:725-731.
4. Walker W.E., Cooley D.A., Duncan J.M., et al. The management of aortoduodenal fistula by in situ replacement of the infected abdominal aortic graft. Ann Surg 1987, 205:727-732.
5. Bailey I.S., Bundred N.J., Pearson H.J., et al. Successful treatment of an infected vascular graft with gentamicin beads. Eur J Vasc Surg 1987, 1:143-144.
6. Benaerts P.J., Ridler B.M., Vercaeren P., et al. Gentamicin beads in vascular surgery: long-term results of implantation. Cardiovasc Surg 1999, 7:447-450.
7. Jorgensen L.G., Sorensen T.S., Lorentzen J.E. Clinical and pharmacokinetic evaluation of gentamycin containing collagen in groin wound infections after vascular reconstruction. Eur J Vasc Surg 1991, 5:87-91.
8. Kwaan J.H., Connolly J.E. Successful management of prosthetic graft infection with continuous povidone-iodine irrigation. Arch Surg 1981, 116:716-720.
9. Popovsky J., Singer S. Infected prosthetic grafts. Local therapy with graft preservation. Arch Surg 1980, 115:203-205.
10. Morris G.E., Friend P.J., Vassallo D.J., et al. Antibiotic irrigation and conservative surgery for major aortic graft infection. J Vasc Surg 1994, 20:88-95.
11. Harvey R.A., Greco R.S. The noncovalent bonding of antibiotics to a polytetrafluoroethylene-benzalkonium graft. Ann Surg 1981, 194:642-647.
12. Greco R.S., Harvey R.A., Smilow P.C., et al. Prevention of vascular prosthetic infection by a benzalkonium-oxacillin bonded polytetrafluoroethylene graft. Surg Gynecol Obstet 1982, 155:28-32.
13. Greco R.S., Harvey R.A. The role of antibiotic bonding in the prevention of vascular prosthetic infections. Ann Surg 1982, 195:168-171.
14. Greco R.S., Harvey R.A. The biochemical bonding of cefoxitin to a microporous polytetrafluoroethylene surface. J Surg Res 1984, 36:237-243.
15. Sobinsky K.R., Flanigan D.P. Antibiotic binding to polytetrafluoroethylene via glucosaminoglycan-keratin luminal coating. Surgery 1986, 100:629-634.
16. Shue W.B., Worosilo S.C., Donetz A.P., et al. Prevention of vascular prosthetic infection with an antibiotic-bonded Dacron graft. J Vasc Surg 1988, 8:600-605.
17. Harvey R.A., Tesoriero J.V., Greco R.S. Noncovalent bonding of penicillin and cefazolin to Dacron. Am J Surg 1984, 147:205-209.
18. Cooley D.A., Romagnoli A., Milam J.D., et al. A method of preparing woven Dacron aortic grafts to prevent interstitial hemorrhage. Cardiovasc Dis 1981, 8:48-52.
19. Powell T.W., Burnham S.J., Johnson G. A passive system using rifampin to create an infection-resistant vascular prosthesis. Surgery 1983, 94:765-769.
20. Moore W.S., Chvapil M., Seiffert G., et al. Development of an infection-resistant vascular prosthesis. Arch Surg 1981, 116:1403-1407.
21. Quinones-Baldrich W.J., Moore W.S., Ziomek S., et al. Development of a "leak-proof," knitted Dacron vascular prosthesis. J Vasc Surg 1986, 3:895-903.
22. Krajicek M., Dvorak J., Chvapil M. Infection-resistant synthetic vascular substitutes. J Cardiovasc Surg (Torino) 1969, 10:453-457.
23. Wakefield T.W., Schaberg D.R., Pierson C.L., et al. Treatment of established prosthetic vascular graft infection with antibiotics preferentially concentrated in leukocytes. Surgery 1987, 102:8-14.
24. Widmer A.F., Frei R., Rajacic Z., et al. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990, 162:96-102.
25. McDougal E.G., Burnham S.J., Johnson G. Rifampin protection against experimental graft sepsis. J Vasc Surg 1986, 4:5-7.
26. Chervu A., Moore W.S., Chvapil M., et al. Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. J Vasc Surg 1991, 13:897-901.
27. Chervu A., Moore W.S., Gelabert H.A., et al. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system. J Vasc Surg 1991, 14:521-524. discussion 524-525.
28. Colburn M.D., Moore W.S., Chvapil M., et al. Use of an antibiotic-bonded graft for in situ reconstruction after prosthetic graft infections. J Vasc Surg 1992, 16:651-658. discussion 658-660.
29. Drury J.K., Ashton T.R., Cunningham J.D., et al. Experimental and clinical experience with a gelatin impregnated Dacron prosthesis. Ann Vasc Surg 1987, 1:542-547.
30. Strachan C.J., Newsom S.W., Ashton T.R. The clinical use of an antibiotic-bonded graft. Eur J Vasc Surg 1991, 5:627-632.
31. Avramovic J., Fletcher J.P. Prevention of prosthetic vascular graft infection by rifampicin impregnation of a protein-sealed Dacron graft in combination with parenteral cephalosporin. J Cardiovasc Surg (Torino) 1992, 33:70-74.
32. Goeau-Brissonniere O., Leport C., Bacourt F., et al. Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft. Ann Vasc Surg 1991, 5:408-412.
33. Gahtan V., Esses G.E., Bandyk D.F., et al. Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts. J Surg Res 1995, 58:105-110.
34. Goeau-Brissonniere O., Mercier F., Nicolas M.H., et al. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft. J Vasc Surg 1994, 19:739-741.
35. Goeau-Brissonniere O., Javerliat I., Koskas F., et al. Rifampin-bonded vascular grafts and postoperative infections. Ann Vasc Surg 2011, 25:134-142.
36. D'Addato M., Curti T., Freyrie A. Prophylaxis of graft infection with rifampicin-bonded Gelseal graft: 2-year follow-up of a prospective clinical trial. Cardiovasc Surg 1996, 4:200-204. Italian Investigators Group.
37. Torsello G., Sandmann W., Gehrt A., et al. In situ replacement of infected vascular prostheses with rifampin-soaked vascular grafts: early results. J Vasc Surg 1993, 17:768-773.
38. Hayes P.D., Nasim A., London N.J., et al. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg 1999, 30:92-98.
39. Young R.M., Cherry K.J., Davis P.M., et al. The results of in situ prosthetic replacement for infected aortic grafts. Am J Surg 1999, 178:136-140.
40. Oderich G.S., Panneton J.M., Bower T.C., et al. Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg 2001, 34:900-908.
41. Bandyk D.F., Novotney M.L., Johnson B.L., et al. Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J Surg Res 2001, 95:44-49.
42. Oderich G.S., Bower T.C., Hofer J., et al. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg 2011, 53:99-106. 107.e1-e7; discussion 106-107.
43. O'Connor S., Andrew P., Batt M., et al. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg 2006, 44:38-45.
44. Koshiko S., Sasajima T., Muraki S., et al. Limitations in the use of rifampicin-gelatin grafts against virulent organisms. J Vasc Surg 2002, 35:779-785.
45. Schmacht D., Armstrong P., Johnson B., et al. Graft infectivity of rifampin and silver-bonded polyester grafts to MRSA contamination. Vasc Endovascular Surg 2005, 39:411-420.
46. Schneider F., O'Connor S., Becquemin J.P. Efficacy of collagen silver-coated polyester and rifampin-soaked vascular grafts to resist infection from MRSA and Escherichia coli in a dog model. Ann Vasc Surg 2008, 22:815-821.